Correlation Between NRx Pharmaceuticals and Inspira Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NRx Pharmaceuticals and Inspira Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRx Pharmaceuticals and Inspira Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRx Pharmaceuticals and Inspira Technologies Oxy, you can compare the effects of market volatilities on NRx Pharmaceuticals and Inspira Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRx Pharmaceuticals with a short position of Inspira Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRx Pharmaceuticals and Inspira Technologies.

Diversification Opportunities for NRx Pharmaceuticals and Inspira Technologies

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between NRx and Inspira is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding NRx Pharmaceuticals and Inspira Technologies Oxy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inspira Technologies Oxy and NRx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRx Pharmaceuticals are associated (or correlated) with Inspira Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inspira Technologies Oxy has no effect on the direction of NRx Pharmaceuticals i.e., NRx Pharmaceuticals and Inspira Technologies go up and down completely randomly.

Pair Corralation between NRx Pharmaceuticals and Inspira Technologies

Assuming the 90 days horizon NRx Pharmaceuticals is expected to generate 1.06 times more return on investment than Inspira Technologies. However, NRx Pharmaceuticals is 1.06 times more volatile than Inspira Technologies Oxy. It trades about 0.25 of its potential returns per unit of risk. Inspira Technologies Oxy is currently generating about 0.03 per unit of risk. If you would invest  5.48  in NRx Pharmaceuticals on October 14, 2024 and sell it today you would earn a total of  28.52  from holding NRx Pharmaceuticals or generate 520.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy88.71%
ValuesDaily Returns

NRx Pharmaceuticals  vs.  Inspira Technologies Oxy

 Performance 
       Timeline  
NRx Pharmaceuticals 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in NRx Pharmaceuticals are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, NRx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Inspira Technologies Oxy 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Inspira Technologies Oxy are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Inspira Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

NRx Pharmaceuticals and Inspira Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NRx Pharmaceuticals and Inspira Technologies

The main advantage of trading using opposite NRx Pharmaceuticals and Inspira Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRx Pharmaceuticals position performs unexpectedly, Inspira Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspira Technologies will offset losses from the drop in Inspira Technologies' long position.
The idea behind NRx Pharmaceuticals and Inspira Technologies Oxy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets